Neurogait is a cutting-edge brand that is revolutionizing neurological diagnosis, monitoring, and treatment. They specialize in Parkinson's and Alzheimer's diagnoses, tackling the challenge of early detection head-on. Traditionally, patients endure a long wait time, averaging 5.

5 years from symptom onset, and often receive under or misdiagnoses. Neurogait offers a game-changing solution using deep learning and your phone's camera, transforming your smartphone into a reliable diagnostic tool from the comfort of your home. Early diagnosis is crucial, as it can significantly enhance the quality of life for individuals with Parkinson's.

The Lancet Study reveals that early diagnosis of Pre-Symptomatic Alzheimer's can even prevent up to 40% of Dementia cases. Neurogait is spearheaded by a team of experts, including seasoned CEO Eyal Fruchtman, skilled Medical Director Gilad Yahalom, and accomplished Chief Operating Officer David Shalev, among others. With their advisory board and lead investigators, Neurogait is committed to creating an AI-based ecosystem for neurological diseases.

Located in Ra'anna, Israel, Neurogait is a brand that brings healthcare right to your fingertips, creating a brighter future for those affected by neurological conditions